搜索
News Center
CDMO for IVD Raw Materials
- Time of issue:2023-02-22
- Views:
(Summary description)AIVD has a variety of active protein development platforms and technologies to meet the needs of different diagnostic reagents for core raw materials.
CDMO for IVD Raw Materials
(Summary description)AIVD has a variety of active protein development platforms and technologies to meet the needs of different diagnostic reagents for core raw materials.
- Categories:News
- Author:AIVD
- Origin:
- Time of issue:2023-02-22 09:35
- Views:
Information
AIVD Biotech is a professional in vitro diagnostic reagent CDMO service provider in China, committed to providing one-stop services for medical institutions, ICL and IVD enterprises in raw material development, test kit development, system establishment, auxiliary registration, production team building, etc.. AIVD has professional R&D team, quality system and registration team, as well as well-equipped diagnostic raw material R&D center, diagnostic test kit R&D center, production center and quality center, which can provide one-stop professional services to help customers to produce products quickly, shorten the product launch cycle and get quick return on investment.
Custom Development and Production of Proteins
AIVD has a variety of active protein development platforms and technologies to meet the needs of different diagnostic reagents for core raw materials.
| Recombinant Antigen R&D Platform | Antibody R&D and Preparation Platform |
| E.coli Expression Platform | Conventional Antibody Production |
| Pichia Pastoris/Saccharomyces Cerevisiae Expression | Nanobody Production |
| Insect Baculovirus Expression | Phage & Yeast Display Technology |
| Mammalian Cell Expression | Antibody Affinity Maturation |
Process
| Development Process | Experiment Schedule | Duration | Experiment Content |
| 1. Immunogen preparation | Preparation of immunogens | 4-5 weeks | Gene synthesis and expression purification |
| 2. Antibody preparation | Phase I: Immunization | 6-8 weeks | Protein immunity or DNA immunity, cellular immunity |
| Phase Ⅱ: Cell fusion and screening | 3-4 weeks | Electrofusion, ELISA screening and retesting | |
| Phase Ⅲ: Subclonal screening and performance validation | 6-8 weeks | Subclone screening, performance verification | |
| Phase IV: Delivery of recombinant antibodies | 3-4 weeks | Hybridoma sequencing, paired antibody preparation, 3-5 mg each |
View and Download AIVD - In Vitro Diagnostic Reagent CDMO Service Provider
Company Advantages
- 2000 sqm standard GMP workshop
- 3000 sqm R&D laboratory, complete biochemical, immune, and molecular diagnostic product lines
- Professional development team, 50+ senior industry experts
- Professional registration team with many years of registration inspection experience
- Perfect quality management system - ISO9001&ISO13485
- Production license of Class II and Class III in vitro diagnostic reagents
 |
 |
 |
 |
 |
 |
View and Download AIVD - In Vitro Diagnostic Reagent CDMO Service Provider
Previous:
None
Previous:
None
Related news
Shenzhen AIVD Biotechnology Co. , LTD.
A4 Building 4th Floor / B5 Building C501, China Merchants Bright Technology Park, Fenghuang Street, Guangming District, Shenzhen, Guangdong Province, China
E-mail：
market@aivdbiotech.com
info@aivdbiotech.com
Tel： +86-755-26165742 +86 18543132823
WhatsApp：+86 18543132823
© 2022 Shenzhen AIVD Biotechnology Co.,LTD. 粤ICP备18093805号